Compounded semaglutide is legal, but it's not regulated in the same way as medications like Ozempic and Wegovy.
WPEC West Palm Beach on MSN4h
The battle over anti-obesity medicationsRocketing demand, legal disputes, and the future of weight loss were all spurred by a new class of anti-obesity medications.
As Eli Lilly ends the year with Zepbound in good supply, TD Cowen analyst Steve Scala asked CEO David Ricks if the company ...
Hosted on MSN10h
We Asked Retail Traders About Eli Lilly’s Biggest Post-Q4 Risk — Most Say It’s The Weight-Loss Drug WarsShares of Eli Lilly finished Thursday 3% higher despite an earnings report that showed sales of its blockbuster GLP-1 ...
The remarkable efficacy of new diabetes and weight loss medicines like Ozempic and Mounjaro have been one of the biggest health stories of recent years. Despite rising rates of diabetes and obesity, ...
Eli Lilly's strong momentum in blockbuster therapies and promising pipeline signals future growth, but competition and ...
Despite heavy demand for its weight-loss and diabetes treatments, limited supply hobbled Eli Lilly's fourth-quarter sales.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback